Work

Developing a systemic monoclonal antibody therapy for the treatment of large burn injuries

Year: 2023
Type: dissertation
Abstract: Burn injuries pose ongoing challenges in patient care, causing slow wound repair, pain, and scarring that result in prolonged morbidity. Flightless I (Flii), a cytoskeletal protein with gelsolin- like domains and a leucine-rich repeat (LRR) domain, is elevated in burn cases. Targeting Flii with function-blocking monoclonal antibodies shows promise in enhancing wound repair. Notably, the systemic administration of Flii-neutralizing antibodies, such as LRRFnAb and MFnAb, has shown significant potential in improving wound healing, specifically in burns. These antibodies effectively enhance the migration and proliferation of skin cells, reduce inflammation, and improve angiogenesis. These findings emphasize the systemic administration of Flii-neutralizing antibodies as a promising approach to facilitate healing in large surface area burns.
Language: English
Subfield: Surgery
Field: Medicine
Open Access status: green
OpenAlex ID: W7222384362
Cites: 356
Cited by:
Related to: 10